Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine in non-intubated thoracoscopic surgery
ChiCTR2400090516Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in lung nodule (SPN) and Pulmonary bulla (2 arms), sponsored by The Third Affiliated Hospital of Chongqing Medical University. Primary endpoint: Degree of central and peripheral pain sensitization. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
lung nodule (SPN)Pulmonary bulla
Beyond the preview
Go deeper on ChiCTR2400090516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090516.